EXABLATE NEURO 4000 TYPE 1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2017-12-07 for EXABLATE NEURO 4000 TYPE 1 manufactured by Insightec, Ltd..

Event Text Entries

[94154836] The retrospective analysis of the treatment data showed that the device performed as intended. Due to the patient complaining of the headache during the treatment, the physician decided to extend the sonication time to up to 28sec, while reducing the power so that the exact amount energy required is unchanged. This approach likely caused a medial-lateral smearing and elongated superior-inferior heat spread. The event of "elongated" sonication thermal spots and the required mitigating steps to manage such events are already part of physician training material: using the exablate sw feature of the low power act temporal mask to manage the effect on spot shape; marking off the hyperostosis with nprs and tilting the traducer (pitch) to avoid this focal area would have potentially resulted in non-smeared tighter focal heat; it is highly recommended to use shorter sonication durations to mitigate a medial-lateral smearing and elongated superior-inferior heat spread. Insightec has discussed this analysis and the mitigating steps (as described above) with the treating physician. Further physician feedback on patient status indicated patient showed good signs of improvement and is satisfied with treatment outcomes. Insightec internal reference number (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[94154837] On (b)(6) 2017, a (b)(6) female patient had an exablate mrgfus procedure to the left vim target for the treatment of essential tremor (et). It was reported that the patient repeatedly stopped sonications due to pain and at the end of the treatment experienced some nausea. Complete tremor relief was reported following the treatment. At the 11-day post-treatment follow up, it was reported that the patient experienced severe facial numbness and temperature sensitivity.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9615058-2017-00005
MDR Report Key7097194
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2017-12-07
Date of Report2017-12-07
Date of Event2017-06-13
Date Facility Aware2017-06-26
Report Date2017-06-26
Date Reported to Mfgr2017-06-26
Date Mfgr Received2017-06-26
Date Added to Maude2017-12-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. IDAN COHEN
Manufacturer Street5 NACHUM HETH STREET P.O. BOX 2039
Manufacturer CityTIRAT CARMEL, ISRAEL 39120
Manufacturer CountryIS
Manufacturer Postal39120
Manufacturer G1INSIGHTEC, LTD.
Manufacturer Street5 NACHUM HETH STREET P.O. BOX 2039
Manufacturer CityTIRAT CARMEL, ISRAEL 31290
Manufacturer CountryIS
Manufacturer Postal Code31290
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEXABLATE NEURO
Generic NameMR-GUIDED FOCUSED ULTRASOUND SYSTEM,
Product CodePOH
Date Received2017-12-07
Model Number4000 TYPE 1
OperatorPHYSICIAN
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINSIGHTEC, LTD.
Manufacturer Address5 NACHUM HETH STREET P.O. BOX 2039 TIRAT CARMEL, ISRAEL 31290 IS 31290


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-12-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.